Moreover, in ovarian cancer, treatment with cisplatin or carboplatin increased IL-6 secretion by cancer-associated fibroblasts, which promoted enrichment of ADLH+ CSC [79], consistent with IL-6 mediated EMT activation in gastric cancer [80] and a tight correlation between CSC plasticity and EMT. Here, IL6 is linked to ovarian cancer.